Recent advances in the aetiology of cryptogenic fibrosing alveolitis

Histopathology

Volumn 37, Issue 5, 2000, Pages 387-392

  Britton, J ^a   Hubbard, R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aetiology; Cryptogenic fibrosing alveolitis

Indexed keywords

CIGARETTE SMOKING; DIET; DISEASE ASSOCIATION; DRUG EXPOSURE; EPSTEIN BARR VIRUS; FIBROSING ALVEOLITIS; GENETIC ASSOCIATION; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LUNG CANCER; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRANSBRONCHIAL BIOPSY;

FOOD HABITS; GREAT BRITAIN; HUMANS; OCCUPATIONAL EXPOSURE; PULMONARY ALVEOLI; PULMONARY FIBROSIS; SMOKING;

EID: 0033747387     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.01098.x     Document Type: Review

References (88)

1. The epidemiology of interstitial lung diseases
2. British Thoracic Society study of cryptogenic fibrosing alveolitis: Current presentation and initial management
3. Idiopathic pulmonary fibrosis
4. The role of high resolution computed tomography in the diagnosis of interstitial lung disease
5. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: A comparison with the 4th Morbidity Survey in General practice (MSGP4)
6. Survival in patients with cryptogenic fibrosing alveolitis: A population based cohort study
7. Acute diffuse interstitial fibrosis of the lungs
8. Mortality rates from cryptogenic fibrosing alveolitis in seven countries
9. Cryptogenic fibrosing alveolitis and Epstein-Barr virus: An Association?
10. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis
11. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis
12. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis
13. Cryptogenic fibrosing alveolitis: Lack of association with Epstein-Barr virus infection
14. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization
15. Evidence that the respiratory tract is a major reservoir for Epstein-Barr Virus
16. Epstein-Barr virus replication in oropharyngeal epithelial cells
17. Epidemiology of Epstein-Barr virus infection in pre-adolescent children: Application of a new salivary method in Edinburgh, Scotland
18. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus
19. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis
20. Idiopathic pulmonary fibrosis and hepatitis C virus infection
21. Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction [
22. Rising mortality from cryptogenic fibrosing alveolitis
23. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust
24. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis
25. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A multicenter case-control study
26. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure
27. Risk of cryptogenic fibrosing alveolitis in metal workers
28. Recent advances in the immunology of interstitial lung disease
29. Hypothesis: Exposure to solvents may cause fibrosing alveolitis
30. The hard metal diseases
31. The respiratory effects of cobalt
32. Asbestos-induced lung disease
33. Drug induced pulmonary disease, an update
34. Interstitial pneumonitis and pulmonary vasculitis in a patient taking an L-tryptophan preparation
35. Dothiepin and fatal fibrosing alveolitis
36. Hypersensitivity reaction to desipramine
37. Acute alveolitis associated with dothiepin treatment
38. Pulmonary infiltrates and fever induced by isoniazid
39. Hypersensitivity pneumonitis induced by trimethoprim
40. Fansidar hypersensitivity pneumonitis
41. Alveolitis associated with sulphamethoxypyridazine
42. Pindolol and pulmonary fibrosis
43. Acebutolol-induced hypersensitivity pneumonitis
44. Provocation test coupled with bronchoalveolar lavage in diagnosis of propranolol-induced hypersensitivity pneumonitis
45. Interstitial pulmonary fibrosis: A new side effect of practolol
46. Acute pulmonary disease caused by phenytoin
47. A case of diphenylhydantoin-induced pneumonitis
48. Rash and pulmonary eosinophilia associated with fenbufen
49. Fenbrufen-associated pneumonitis
50. Sulindac pneumonitis
51. Pulmonary fibrosis associated with nabumetone
52. Pulmonary infiltrations induced by tolfenamic acid
53. Exposure to commonly prescribed drugs and the aetiology of cryptogenic fibrosing alveolitis: A case-control study
54. Lung as a reservoir for anti-depressants in pharmacokinetic drug interactions
55. Antidepressant exposure and risk of cryptogenic fibrosing alveolitis (CFA): A case-control study using the General Practice Research Database (GPRD)
56. Pulmonary fibrosis: Cytokines in the balance
57. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize Prostaglandin E2 and to express cyclooxygenase-2
58. Cryptogenic fibrosing alveolitis: Clinical features and there influence on survival
59. Natural history and treated course of usual and desquamative interstitial pneumonia
60. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis
61. Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis
62. The prognosis of cryptogenic fibrosing alveolitis
63. Cryptogenic fibrosing alveolitis and lung cancer
64. Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer
65. Lung cancer and cryptogenic fibrosing alveolitis: A population based cohort study
66. Genetic study of idiopathic pulmonary fibrosis
67. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom
68. Familial cryptogenic fibrosing alveolitis: A case report
69. Inherited forms of interstitial lung disease
70. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members
71. Antigens in diffuse fibrosing alveolitis
72. Distribution of HLA antigens in idiopathic pulmonary fibrosis
73. Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2
74. Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes
75. HLA in crytogenic fibrosing alveolitis
76. HL-A antigens and fibrosing alveolitis
77. High prevalences of HLA-B15 and HLA-Dw6 in patients with cruptogenic fibrosing alveolitis
78. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis
79. Alpha-1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis
80. Alpha-1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: A case-control study
81. Association of an interleukin-1 receptor antagonist polymorphism with idiopathic pulmonary fibrosis
82. Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis
83. Oxidised bronchoalveolar lavage fluid proteins in patients with interstitial lung disease
84. The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort
85. Taurine and niacin offer a novel therapeutic modality in prevention of chemically-induced pulmonary fibrosis in hamsters
86. Gamma linolenic acid-enriched diets attenuates bleomycin induced lung fibrosis
87. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin
88. Does eating fish and fresh vegetables protect against the risk of dying from cryptogenic fibrosing alveolitis